§ Cases

Work that moved
the needle.

Anonymised illustrations of the work we do. The mandates are real; the details are protected by the confidentiality our clients rightly expect.

Quantum TechnologyCase 01 · Quantum Technology
Communication & PR / Completed

From quantum complexity to high-impact coverage!

Szpirt & Company helped translate a highly technical quantum investment story into clear, relevant media coverage. Through targeted outreach to leading Danish financial and technology journalists, we secured high-impact coverage and strengthened awareness among key Danish stakeholders.

Molecule – Szpirt & CompanyCase 02 · Pharma
Business Development / Completed

Supporting market access for a leading pharmaceutical company.

Szpirt & Company supported a leading international pharmaceutical company in strengthening its position and market access in Denmark. Through stakeholder mapping, strategic dialogue and engagement with insurance companies, we identified opportunities to integrate the client’s treatments into existing healthcare packages, potentially expanding patient access and creating new commercial opportunities.

Horizon EuropeCase 03 · Agriculture · Horizon Europe
Communication & PR / Ongoing

Making sustainable farming knowledge usable across Europe.

Helping a Horizon Europe consortium turn proven research and on-farm practice into stories and resources small-scale farmers can use.

Case 04IPO · Cleantech
Communication & PR

Preparing a Nordic clean-energy company for its public market debut.

Twelve months of structured communication preparation ahead of a Copenhagen Stock Exchange listing. We built the investor narrative, prepared management for analyst and media scrutiny, and coordinated the full IPO communications programme.

Outcomes
  • ✓Oversubscribed book
  • ✓Consistent narrative across roadshow markets
  • ✓Zero adverse media incidents on listing day
Case 05Market Entry · Life Sciences
Business Development

Mapping the Danish biotech ecosystem for a global pharma entrant.

A top-10 global pharmaceutical company needed a credible Nordic partner to accelerate its rare disease pipeline. We identified, qualified, and facilitated introductions to seven candidate organisations — three of which progressed to term sheets.

Outcomes
  • ✓Seven qualified introductions
  • ✓Three term-sheet processes initiated
  • ✓Full commercial due diligence support
Case 06Policy · EU
Government Affairs

Shaping the Danish position on the EU AI Act.

A coalition of Danish technology and financial-services companies needed a unified position paper and a coordinated lobbying approach ahead of the trilogue finalisation. We drafted the policy brief, mapped decision-makers in the Parliament and Council, and coordinated three rounds of direct stakeholder engagement.

Outcomes
  • ✓Position paper adopted by the industry association
  • ✓Three direct meetings with rapporteur's office
  • ✓Key amendment language reflected in final text
Case 07Crisis · Communication
Communication & PR

Advising a listed industrial group through a leadership transition.

When an unexpected CEO departure coincided with a profit warning, we were retained within 24 hours. We designed the disclosure strategy, prepared the Board's communication, advised on media handling, and supported the interim CEO through the first investor calls.

Outcomes
  • ✓Share price stabilised within 48 hours
  • ✓No governance escalation from major shareholders
  • ✓Smooth external announcement of permanent appointment
Your situation

Working through
something similar?

Begin a conversation →